Lampiran 1. Alur Penelitian
SAMPEL : KASUS MALOKLUSI KLAS I BESAR SUDUT ANB 0-4
USIA 18-35 TAHUN
0
PENGUKURAN SEBELUM PENCABUTAN EMPAT PREMOLAR PERTAMA
1.
SNA
2.
SNB
3.
ANB
4.
PNS-ANS
5.
Ar-Go
6.
Me
7.
FH
8.
MP
PENCABUTAN EMPAT PREMOLAR PERTAMA
PENGUKURAN SETELAH PENCABUTAN
1.
SNA
2.
SNB
3.
ANB
4.
PNS-ANS
5.
Ar-Go
6.
Me
7.
FH
8.
MP
PERHITUNGAN PERUBAHAN INDEKS TINGGI WAJAH (FHI
)
:
TINGGI WAJAH ANTERIOR
(AFH)
TINGGI WAJAH POSTERIOR
(PFH)
SUDUT FRANKFORT MANDIBULA
(FMA)
DATA
ANALISA DATA
HASIL
Lampiran 2. Jadwal Penelitian 2011 - 2012
No
Kegiatan
Waktu Pelaksanaan (Bulan)
7
12
1
3
4
5
6
7
8
11
1.
Penelusuran Kepustakaan
x
2.
Persetujuan Judul
x
3.
Pembuatan Proposal dan Diskusi
xxxx xxxx
x
4.
Seminar Proposal
x
x
5.
Pengambilan data
xx
xxx
xxx xxx
6.
Pengolahan Data
xxx
7.
Penulisan Laporan
xxx
8.
Seminar hasil
x
9.
Perbaikan dan Penjilidan
x
Lampiran 3. Data SPSS
Paired Samples Statistics
70,346
13
6,8111
1,8891
71,500
13
6,5796
1,8249
54,538
13
5,3908
1,4951
56,308
13
6,0880
1,6885
,78092
13
,098681
,027369
,79023
13
,084039
,023308
26,3077
13
7,19820
1,99642
25,1154
13
6,64628
1,84335
9,1538
13
6,14880
1,70537
7,0385
13
3,83222
1,06287
AFH Pra Treatmant
AFH Pasca Treatmant
Pair
1
PFH Pra Treatment
PFH Pasca Treatment
Pair
2
FHI Pra Treatment
FHI PascaTreatment
Pair
3
FMA Pra Treatment
FMA Pasca Treatment
Pair
4
OCC Pra Treatment
OCC Pasca Treatment
Pair
5
Mean
N
Std. Deviation
Std. Error
Mean
Paired Samples Correlations
13
,915
,000
13
,416
,157
13
,523
,067
13
,847
,000
13
,654
,015
AFH Pra Treatmant &
AFH Pasca Treatmant
Pair
1
PFH Pra Treatment &
PFH Pasca Treatment
Pair
2
FHI Pra Treatment &
FHI PascaTreatment
Pair
3
FMA Pra Treatment &
FMA Pasca Treatment
Pair
4
OCC Pra Treatment &
OCC Pasca Treatment
Pair
5
N
Correlation
Sig.
Pa ired Sa mples Test
-1, 1538
2,7642
,7667
-2, 8243
,5166
-1, 505
12
,158
-1, 7692
6,2304
1,7280
-5, 5342
1,9957
-1, 024
12
,326
-,009308
,090150
,025003
-,063785
,045170
-,372
12
,716
1,19231
3,86511
1,07199
-1, 14336
3,52797
1,112
12
,288
2,11538
4,65544
1,29119
-,69787
4,92864
1,638
12
,127
AFH P ra Treat mant
-AFH P asc a Treatmant
Pair
1
PFH P ra Treat ment
-PFH P asc a Treatment
Pair
2
FHI Pra Treatment
-FHI PascaTreatment
Pair
3
FMA P ra Treat ment
-FMA P asc a Treatment
Pair
4
OCC P ra Treat ment
-OCC P asc a Treatment
Pair
5
Mean
St d. Deviat ion
St d. E rror
Mean
Lower
Upper
95% Confidenc e
Int erval of t he
Difference
Paired Differences
t
df
Sig. (2-tailed)
Correl ations
1 ,141 -,693** ,915** ,333 -,457 ,625* ,662* -,006 ,085
,645 ,009 ,000 ,266 ,116 ,022 ,014 ,984 ,783
13 13 13 13 13 13 13 13 13 13
,141 1 ,614* ,184 ,416 ,231 -,543 -,349 -,614* -,424
,645 ,026 ,548 ,157 ,448 ,055 ,242 ,026 ,149
13 13 13 13 13 13 13 13 13 13
-,693** ,614* 1 -,604* ,022 ,523 -,893** -,791** -,435 -,374
,009 ,026 ,029 ,944 ,067 ,000 ,001 ,138 ,208
13 13 13 13 13 13 13 13 13 13
,915** ,184 -,604* 1 ,399 -,452 ,456 ,495 -,171 -,107
,000 ,548 ,029 ,176 ,121 ,118 ,085 ,577 ,727
13 13 13 13 13 13 13 13 13 13
,333 ,416 ,022 ,399 1 ,634* -,198 ,066 -,274 -,172
,266 ,157 ,944 ,176 ,020 ,516 ,830 ,365 ,574
13 13 13 13 13 13 13 13 13 13
-,457 ,231 ,523 -,452 ,634* 1 -,580* -,347 -,097 -,075
,116 ,448 ,067 ,121 ,020 ,038 ,246 ,752 ,808
13 13 13 13 13 13 13 13 13 13
,625* -,543 -,893** ,456 -,198 -,580* 1 ,847** ,540 ,453
,022 ,055 ,000 ,118 ,516 ,038 ,000 ,057 ,120
13 13 13 13 13 13 13 13 13 13
,662* -,349 -,791** ,495 ,066 -,347 ,847** 1 ,568* ,676*
,014 ,242 ,001 ,085 ,830 ,246 ,000 ,043 ,011
13 13 13 13 13 13 13 13 13 13
-,006 -,614* -,435 -,171 -,274 -,097 ,540 ,568* 1 ,654*
,984 ,026 ,138 ,577 ,365 ,752 ,057 ,043 ,015
13 13 13 13 13 13 13 13 13 13
,085 -,424 -,374 -,107 -,172 -,075 ,453 ,676* ,654* 1
,783 ,149 ,208 ,727 ,574 ,808 ,120 ,011 ,015
13 13 13 13 13 13 13 13 13 13
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N
Pearson Correlation Sig. (2-tailed) N AFH P ra Treatmant
PFH P ra Treatment
FHI Pra Treatment
AFH P asc a Treatmant
PFH P asc a Treatment
FHI PascaTreatment
FMA P ra Treat ment
FMA P asc a Treatment
OCC P ra Treat ment
OCC P asc a Treatment
AFH P ra Treatmant
PFH P ra Treatment
FHI Pra Treatment
Correlation is s ignificant at the 0.01 level (2-tailed). **.
Correlation is s ignificant at the 0.05 level (2-tailed). *.
